These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 16110886)

  • 41. Veterinary parasitic vaccines: pitfalls and future directions.
    Vercruysse J; Knox DP; Schetters TP; Willadsen P
    Trends Parasitol; 2004 Oct; 20(10):488-92. PubMed ID: 15363443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preerythrocytic malaria vaccine development.
    Mikolajczak SA; Aly AS; Kappe SH
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulatory requirements for vaccine authorisation.
    Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
    Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora.
    Innes EA; Vermeulen AN
    Parasitology; 2006; 133 Suppl():S145-68. PubMed ID: 17274844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New concepts in vaccine development in malaria.
    Kanoi BN; Egwang TG
    Curr Opin Infect Dis; 2007 Jun; 20(3):311-6. PubMed ID: 17471043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progress towards a Leishmania vaccine.
    Tabbara KS
    Saudi Med J; 2006 Jul; 27(7):942-50. PubMed ID: 16830009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Companies Claim to Fame and their scientific challenges in vaccine development.
    Boon L
    Immunol Lett; 2009 Feb; 122(2):123-5. PubMed ID: 19101592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mucosal delivery of vaccines in domestic animals.
    Gerdts V; Mutwiri GK; Tikoo SK; Babiuk LA
    Vet Res; 2006; 37(3):487-510. PubMed ID: 16611560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccination in food animal populations.
    van Oirschot JT
    Vaccine; 1994 Apr; 12(5):415-8. PubMed ID: 8023549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reverse vaccinology in the 21st century: improvements over the original design.
    Donati C; Rappuoli R
    Ann N Y Acad Sci; 2013 May; 1285():115-32. PubMed ID: 23527566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 'Bioengineered Bugs' - a patho-biotechnology approach to probiotic research and applications.
    Sleator RD; Hill C
    Med Hypotheses; 2008; 70(1):167-9. PubMed ID: 17452084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals.
    van Drunen Littel-van den Hurk S; Gerdts V; Loehr BI; Pontarollo R; Rankin R; Uwiera R; Babiuk LA
    Adv Drug Deliv Rev; 2000 Sep; 43(1):13-28. PubMed ID: 10967218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Challenges and issues of early life vaccination in animals and humans.
    Pastoret PP
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S2-3. PubMed ID: 17574267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccination: a management tool in veterinary medicine.
    Babiuk LA
    Vet J; 2002 Nov; 164(3):188-201. PubMed ID: 12505392
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Control and eradication of O.I.E. list A diseases--the approach of the European Union to the use of vaccines.
    Laddomada A
    Dev Biol (Basel); 2003; 114():269-80. PubMed ID: 14677697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccine development in the 21st century: a time of living dangerously.
    Vordermeier M; Hogarth P
    Vet J; 2005 Nov; 170(3):271-2. PubMed ID: 16266840
    [No Abstract]   [Full Text] [Related]  

  • 58. Future of biotechnology-based control of disease in marine invertebrates.
    Mialhe E; Bachere E; Boulo V; Cadoret JP; Rousseau C; Cedeño V; Saraiva E; Carrera L; Calderon J; Colwell RR
    Mol Mar Biol Biotechnol; 1995 Dec; 4(4):275-83. PubMed ID: 8541979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biotechnology offers revolution to fish health management.
    Adams A; Thompson KD
    Trends Biotechnol; 2006 May; 24(5):201-5. PubMed ID: 16564587
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current status of vaccine development against Theileria parasites.
    Morrison WI; McKeever DJ
    Parasitology; 2006; 133 Suppl():S169-87. PubMed ID: 17274845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.